These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 53211
1. Antigenic specificities of the cell-mediated anti-tumor reactions in the MSV system studied by the secondary chromium release test. Senik A, Gisselbrecht S, Levy JP. Int J Cancer; 1975 Dec 15; 16(6):960-70. PubMed ID: 53211 [Abstract] [Full Text] [Related]
3. Significance of the proline assay in the study of anti-MSV cell-mediated immune reactions. Henin Y, Gomard E, Gisselbrecht S, Levy JP. Br J Cancer; 1979 Jan 15; 39(1):51-63. PubMed ID: 215185 [Abstract] [Full Text] [Related]
9. The specificity of effector T cells activated by tumours induced by murine oncornaviruses. Shellam GR, Knight RA, Mitchison NA, Gorczynski RM, Maoz A. Transplant Rev; 1976 Apr 15; 29():249-76. PubMed ID: 58459 [No Abstract] [Full Text] [Related]
10. Antigenic specificity of cell-mediated antitumor reaction in the MSV system. Leclerc JC, Gomard E, Levy JP, Senik A. Bibl Haematol; 1975 Oct 15; (43):173-6. PubMed ID: 60997 [No Abstract] [Full Text] [Related]
11. In vitro induction of tumor-specific immunity. II. Activation of cytotoxic lymphocytes to murine oncofetal antigens. Chism SE, Burton RC, Warner NL. J Natl Cancer Inst; 1976 Aug 15; 57(2):377-87. PubMed ID: 63560 [Abstract] [Full Text] [Related]
12. Comparative in vitro studies on effector cell diversity in the cellular immune response to murine sarcoma virus (MSV)-induced tumors in mice. Plata F, Gomard E, Leclerc JC, Levy JP. J Immunol; 1974 Apr 15; 112(4):1477-87. PubMed ID: 4360862 [No Abstract] [Full Text] [Related]
14. Cell-mediated reaction against tumors induced by oncornaviruses. I. Kinetics and specificity of the immune response in murine sarcoma virus (MSV)-induced tumors and transplanted lymphomas. Leclerc JC, Gomard E, Levy JP. Int J Cancer; 1972 Nov 15; 10(3):589-601. PubMed ID: 4128690 [No Abstract] [Full Text] [Related]
15. Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus. Herberman RB, Aoki T, Nunn M, Lavrin DH, Soares N, Gazdar A, Holden H, Chang KS. J Natl Cancer Inst; 1974 Oct 15; 53(4):1103-11. PubMed ID: 4139276 [No Abstract] [Full Text] [Related]
16. Evaluation of the cell-mediated immune response to murine sarcoma virus by (125I)iododeoxyuridine assay and comparison with chromium 51 and microcytotoxicity assays. Fossati G, Holden HT, Herberman RB. Cancer Res; 1975 Sep 15; 35(9):2600-8. PubMed ID: 167966 [Abstract] [Full Text] [Related]
18. Murine sarcoma virus (MSV)-induced tumors in mice. I. Distribution of MSV-immune cytolytic T lymphocytes in vivo. Plata F, Sordat B. Int J Cancer; 1977 Feb 15; 19(2):205-11. PubMed ID: 300075 [Abstract] [Full Text] [Related]
19. Characterization to effector lymphocytes associated with immunity to murine sarcoma virus (MSV)-induced tumors. II. Repeated stimulation and proliferation in vitro of specific cytolytic T lymphocytes. Plata F, Jongeneel CV. J Immunol; 1977 Aug 15; 119(2):623-9. PubMed ID: 196025 [No Abstract] [Full Text] [Related]
20. Antigenic changes of DBA/2J mastocytoma cells when grown in the BALB/c mouse. Wolf JE, Faanes RB, Choi YS. J Natl Cancer Inst; 1977 May 15; 58(5):1407-12. PubMed ID: 67213 [Abstract] [Full Text] [Related] Page: [Next] [New Search]